Spring Bank Pharmaceuticals Inc.
Industry
- Biotechnology
- Pharmaceuticals
Other Names/Subsidiaries
- F-star Therapeutics, Inc.
Latest on Spring Bank Pharmaceuticals Inc.
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AstraZeneca Offloads Phase III-Ready Su
Antivirals are typically used as chronic treatment to suppress the hepatitis B virus, but several companies are attempting to achieve virtual cures of the virus. Assembly Biosciences, Inc. , focused
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie Opts Not To Continue Leber Conge
Recent follow-on public offerings (FOPOs) defied the year-to-date decline in biopharmaceutical stock values with FOPOs as large as $325m for Blueprint Medicines Corp. and $320.8m for Zymeworks Inc.